Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Tables)

Intangible Assets (Tables)

3 Months Ended

Feb. 28, 2021

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets were as follows as of February 28, 2021 and November 30, 2020:

		Useful lives		February 28, 2021				November 30, 2020
Patents and Domain Names		10-20 years		$	623,980			$	234,570
Less: Accumulated amortization					(50,055	)			(47,150	)
License agreement		10 years			470,000				470,000
Less: Intangible asset impairment					(185,000	)			(185,000	)
Less: Accumulated amortization					(184,255	)			(178,443	)
Customer relationships-PrepaCyte®CB		15 years			41,000				41,000
Less: Intangible asset impairment					(26,267	)			(26,267	)
Less: Accumulated amortization					(7,322	)			(7,122	)
Brand		1 year			31,000				31,000
Less: Accumulated amortization					(31,000	)			(31,000	)
Customer relationships – Cord:Use		30 years			960,000				960,000
Less: Accumulated amortization					(88,000	)			(80,000	)
Net Intangible Assets				$	1,554,081			$	1,181,588